Trinity Biotech (TRIB) Raw Materials (2016 - 2025)
Trinity Biotech (TRIB) posted Raw Materials of $11.5 million for Q4 2025, up 14.48% sequentially from $10.0 million in Q4 2024, and up 14.48% YoY from $10.0 million in Q4 2024.
Trinity Biotech (TRIB) Raw Materials (2016 - 2025) Analysis & Trends
Trinity Biotech has reported Raw Materials for 7 years, with the latest figure at $11.5 million in Q4 2025.
- Quarterly Raw Materials rose 14.48% year-over-year to $11.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.5 million (up 14.48% YoY) and the FY2025 annual result came in at $11.5 million, up 14.48% from the prior year.
- Raw Materials climbed to $11.5 million in Q4 2025 per TRIB's latest filing, from $10.0 million in the prior quarter.
- Over five years, Raw Materials peaked at $11.5 million in Q4 2025 and troughed at $10.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.49 Mn |
| Dec 31, 2024 | 10.03 Mn |
| Dec 31, 2020 | 12.17 Mn |
| Dec 31, 2019 | 12.65 Mn |
| Dec 31, 2018 | 10.56 Mn |
| Dec 31, 2017 | 10.35 Mn |
| Dec 31, 2016 | 9.18 Mn |